Log In
BCIQ
Print this Print this
 

BRM211

  Manage Alerts
Collapse Summary General Information
Company BRIM Biotechnology Inc.
DescriptionSmall molecule with anti-viral activity against DENV1, DENV2, DENV3, and DENV4
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationDengue fever
Indication DetailsTreat dengue virus infection
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today